Top 16 Sitryx Therapeutics investors
The most complete profiles first. Showing 16 of 16.
Christoph WestphalVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more
Verified email available
Eugene HillVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Verified email available
Jack KenneyVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Paul LaVioletteVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more
Verified email available
Rich AldrichVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more
Verified email available
Tom FlynnVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
David DonabedianVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more
Verified email available
Elizabeth Blake SchwertVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
Mike RossVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
Gregory Madden
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more
Contact details available
Houman Ashrafian
Venture Capital, Investor · United Kingdom
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Contact details available
Michael Balmuth
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Contact details available
Brent Faduski
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Carl Culicchia
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Lea Hachigian
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more
Contact details available
Maina Bhaman
Venture Capital, Private Equity Firm, Investor · United Kingdom
SeedBiotechnologyClean TechnologyElectronic Health Records (EHR)Health and Hospital ServicesPortfolio: Autifony Therapeutics, Psioxus Therapeutics, Kuur Therapeutics, Sitryx Therapeutics and 3 more
Contact details available
Frequently asked questions
How many Sitryx Therapeutics investors are on Angel Roster?
Angel Roster lists 16 Sitryx Therapeutics investors. 8 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (16), Private Equity Firms (7) and Founder-Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Sitryx Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (10).
Where are Sitryx Therapeutics investors based?
Most are based in the United States (14) and the United Kingdom (2).
Which companies have Sitryx Therapeutics investors backed?
The most-backed portfolio companies among them are KalVista Pharmaceuticals (15), Pulmocide (15), Bicycle Therapeutics (15), Autifony Therapeutics (12) and TopiVert (12).
How do I contact Sitryx Therapeutics investors?
Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.